PDF DatasheetInfluenza H3N2 Brisbane Recombinant Protein Product Attributes
Product Type: Recombinant Protein
Recombinant H3N2 Brisbane based upon sequence from Influenza
Available Tags: Untagged
Protein Construction: A cDNA sequence encoding the sequence of H3N2 Brisbane was constructred and used to recombinantly synthesize the protein.
Recommended Applications: See Application Notes
Application Notes
Other Applications: Tested with anti-influenza A monoclonal antibodies in ELISA. Serological studies of influenza A virus, immunogen for antibody production.
Bioactivity Data: Untested
Purity: Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Reconstitution Instructions: |||
Endotoxin Levels: Not Determined. Testing recommended prior to use in cell culture and can be performed upon request.
Buffer: The H3N2 A/Brisbane/10/07 solution contains STE, 0.1% sodium azide (NaN3) and 0.005% thimerosal.
Storage Conditions: A/Brisbane/10/07although stable 4°C for 4 weeks, should be stored below -18°C. Please prevent freeze-thaw cycles.
Physical Appearance: Sterile Filtered whitish (milky) solution.
Selected References
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionpublication: The Rockefeller University Press, doi: 10.1084/jem.20101352 © 2011 Wrammert et al. Link:http://jem.rupress.org/content/early/2011/01/06/jem.20101352.full
Limitations and Performance Guarantee
enQuire Bio’s products are guaranteed and approved for RESEARCH USE ONLY or manufacturing purposes. This product may not be used as a pharmaceutical agent, or other product intended for human consumption without meeting additional regulatory requirements. This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.
There are no reviews yet.